Partners4Access

We are specialists in orphan drug access, partnering with our clients to achieve launch success worldwide. Through our initiatives, we are able to inform and shape the conversation of orphan drugs. Our expert team is specialised in several key areas to optimize price and access potential. Our focus areas include: orphan drug pricing and market access strategy; bespoke access roadmap; rare disease foresights; evidence mitigation solutions; access team excellence. As one of the only consultancies with comprehensive experience in cell and gene therapies, we are excellently placed to help you with your commercialization plans.

At P4A, we believe in striking an equilibrium in the rare disease world. That means helping drive access to the most appropriate treatments for patients and physicians, a fair return on investment for manufacturers at an affordable proposition for payers

Enlightened. Thinking. Applied